Sam Kintz, co-founder, and CEO of Enliven Therapeutics, speaks with Venrock partner Nimish Shah about the journey that led him to found Enliven. Kintz delves into lessons learned during his time at Roche Venture Fund, and how his time at Stemcentrx and Abbvie revealed what truly matters most to him – being a part of an entire drug development story. Kintz discusses his decision to pursue a reverse merger (and how he persuaded everyone involved to follow this path), what defines a great leader, and shares the best advice he received from one of his mentors.
